IDEXX Laboratories, Inc.

Informe acción NasdaqGS:IDXX

Capitalización de mercado: US$40.9b

IDEXX Laboratories Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de IDEXX Laboratories de 9.9% y 8.7% por año respectivamente. Se prevé que el BPA crezca en un 11.1% al año. Se espera que la rentabilidad financiera sea de 35.6% en 3 años.

Información clave

9.9%

Tasa de crecimiento de los beneficios

11.1%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment16.7%
Tasa de crecimiento de los ingresos8.7%
Rentabilidad financiera futura35.6%
Cobertura de analistas

Good

Última actualización28 May 2024

Actualizaciones recientes sobre el crecimiento futuro

IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 03
IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

Jun 04
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

Should You Think About Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX) Now?

May 21
Should You Think About Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX) Now?

IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 03
IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

What IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) P/E Is Not Telling You

Apr 27
What IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) P/E Is Not Telling You

IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet

Apr 11
IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet

IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)

Apr 08

Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jan 30
Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified

Jan 16

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

Jan 15
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit

Dec 31
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit

IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly

Dec 15
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly

Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Oct 26
Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

Oct 10
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Sep 07
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jul 04
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

May 31
These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

Apr 05
At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly

Feb 22
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly

Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Jan 05
Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Nov 24
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Sep 20
When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Outstanding Business, But Valuation Is Key

Aug 15

These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

Aug 15
These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

IDEXX Laboratories Stock Is Very Expensive

Aug 08

IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M

Aug 02

Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?

Jul 26
Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?

Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today

Jul 12
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today

Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jun 16
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Great Business, But Still Overvalued

May 25

We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

May 06
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$474 Based On Its Intrinsic Value?

Apr 23
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$474 Based On Its Intrinsic Value?

With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Apr 09
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Mar 07
Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories And Its Real Value

Feb 02

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:IDXX - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20264,7771,1671,0681,2269
12/31/20254,3391,0369831,10611
12/31/20243,9449228851,09711
3/31/20243,725867797921N/A
12/31/20233,661845773907N/A
9/30/20233,588823680830N/A
6/30/20233,514791593747N/A
3/31/20233,431699456612N/A
12/31/20223,367679384543N/A
9/30/20223,340670438580N/A
6/30/20223,309664429578N/A
3/31/20223,274735605746N/A
12/31/20213,215745636756N/A
9/30/20213,135757663765N/A
6/30/20213,047728694770N/A
3/31/20212,858674666745N/A
12/31/20202,707582540648N/A
9/30/20202,591497445585N/A
6/30/20202,475460366524N/A
3/31/20202,457437286453N/A
12/31/20192,407428304459N/A
9/30/20192,351423290439N/A
6/30/20192,291407274418N/A
3/31/20192,252390262400N/A
12/31/20182,213377277400N/A
9/30/20182,170330280386N/A
6/30/20182,117307296386N/A
3/31/20182,045284300377N/A
12/31/20171,969263N/A373N/A
9/30/20171,906277N/A353N/A
6/30/20171,862263N/A343N/A
3/31/20171,820245N/A343N/A
12/31/20161,775222N/A339N/A
9/30/20161,732214N/A312N/A
6/30/20161,690202N/A289N/A
3/31/20161,637192N/A258N/A
12/31/20151,602192N/A222N/A
9/30/20151,554174N/A170N/A
6/30/20151,531182N/A186N/A
3/31/20151,508182N/A188N/A
12/31/20141,486182N/A236N/A
9/30/20141,488199N/A274N/A
6/30/20141,443193N/A259N/A
3/31/20141,405190N/A258N/A
12/31/20131,377188N/A246N/A
9/30/20131,343188N/A250N/A
6/30/20131,320185N/A246N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (9.9% al año) de IDXX es superior a la tasa de ahorro (2.4%).

Beneficios vs. Mercado: Se prevé que los beneficios (9.9% al año) de IDXX crezcan menos que el mercado US (14.8% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de IDXX crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (8.7% al año) de IDXX crezcan más rápidamente que los del mercado US (8.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 8.7% al año) de IDXX crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de IDXX sea alta dentro de 3 años (35.6%)

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y